Rwanda Leads $17M Vaccine Trial for Mosquito-Borne Disease

African researchers are racing to develop the continent's first chikungunya vaccine designed specifically for children and local populations.

Rwanda is leading a four-year, $17 million partnership across four African nations to test and eventually manufacture the life-saving vaccine.